Avoid top-down narratives; seek independent sourcing and support. Government-devised hospital standard of care for Covid made pharma rich and people worse.

Prompted by research recently published in The New England Journal of Medicine, I’ve updated this curation of references documenting harms from hospital Covid standard of care. Excerpts below.

1. Bottom Line

2. Executive Summary

3. Excerpt: Paxlovid Was Not Successful

4. Covid “Public Health” Protocols: Failure & Harm

5. Free Reference Guide

6. The Wellness Professional’s Trusted Hub: Premium Tools from $12/month

Outcomes:

• The majority of Covid patients put on ventilators died.

• Molnupiravir increased infection.

• Paxlovid didn’t improve outcomes.

• Midazolam causes life-threatening breathing problems, permanent brain injury and death.

See the full curation for references on each of these:

• Majority of Covid Patients Put on Ventilators Died — Reporting from hospitals in April 2020 + later summary reports show that the majority of Covid patients put on ventilators died.

• Government-Devised, Costly Standard of Care Made Pharma Rich and Patients Worse — Molnupiravir increased infection. Paxlovid didn’t improve outcomes. Even so, U.S. taxpayers payed billions for a “stockpile delivery” of paxlovid in 2024, leading to “better-than-expected” sales for Pfizer.

• Research: Midazolam Injections Killed Covid Patients — “This paper shows that the UK spike in deaths, wrongly attributed to Covid-19 in April 2020, was not due to SARS-CoV-2 virus, which was largely absent, but was due to the widespread use of Midazolam injections.” – Dr. Wilson Sy, Director Investment Analytics Research, Australia

• Remdesivir: Failed and Deadly Drug (curated separately here) — In 2019, Remdesivir was deemed too deadly to use. In 2020, government official Anthony Fauci mandated and incentivized this failed and deadly drug as Covid standard of care. Hospitals succumbed to financial pressures to use Remdesivir. More than 30 references.

1. Jun 2, 2022 — Paxlovid: CDC Director Issues Alert on Pfizer’s Covid Pill… ‘If you take Paxlovid, you might get symptoms again,’ Walensky said.” — Dr. Paul Alexander link

2. Aug 3, 2022 — If Paxlovid Causes More Covid, Why Has the White House Spent Billions on It? — David Gortler, The Federalist link

3. April 2023— Paxlovid: A Regulatory Gamble; “With limited evidence supporting a broad use in America, where most adults are vaccinated, the Biden administration has encouraged the widespread use of Paxlovid, allowing pharmacists to prescribe it and deliver it via DoorDash. A number of preliminary findings suggest that Paxlovid may ultimately be found to be ineffective in vaccinated individuals, or almost certainly cost-ineffective. Redistributing a portion of Paxlovid spending toward clinical trials would have been a better use of taxpayer dollars. — Dr. Milos D. Miljkovic MD & Dr. Vinay Prasad MD, MPH, The American Journal of Medicine link

4. Oct 31, 2023 — Paxlovid Does Not Work Against ‘Long Covid’: Study. Out of the 31 long Covid conditions, Paxlovid was found to minimize the incidence of only one. — Naveen Athrappully, The Epoch Times link

5. Dec 22, 2023 — Scotland’s Covid Drug Cocktail Raises Concerns; “A key nurse whistleblower has just received a public gag order from the Scottish Covid inquiry”— The Highwire link

6. Jan 4, 2024 — Association of nirmatrelvir for acute SARS-CoV-2 infection with subsequent Long Covid symptoms in an observational cohort study; “Among those treated with nirmatrelvir, 57/353 (16%) reported Long Covid symptoms compared to 176/1258 (14%) untreated.” — Matthew S. Durstenfeld et al, Journal of Medical Virology link

7. Jan 5, 2024 — Paxlovid Doesn’t Reduce Risk of Long Covid, Potentially Linked to Rebound Symptoms: Study. Researchers found little difference in outcomes between Paxlovid users and nonusers. They also found 1 in 5 users experienced rebound symptoms. — A. C. Dahnke, The Epoch Times link

8. Mar 13, 2024 — Covid-19 Pill Paxlovid No Longer Authorized in US for Emergency Use — A. C. Dahnke, The Epoch Times link

9. Apr 3, 2024 — Paxlovid Fails to Shorten Covid in Standard-Risk and Vaccinated At-Risk Patients — Katherine Kahn, MedPageToday link

10. Apr 4, 2024 — Among Fully Vaccinated, Study Shows Paxlovid Does Not Shorten Symptoms — Stephanie Soucheray, CIDRAP link

11. Apr 13, 2024 — Is Paxlovid a Dud? “Of all the antiviral drugs for Covid-19, Pfizer’s Paxlovid has been the most successful. Not for its safety and efficacy, but for its ability to earn the company billions in profits despite being largely ineffective for most people.” — Maryanne Demasi, Brownstone Institute link

12. Jun 6, 2024 — Paxlovid Trial Flops for Covid Pneumonia: Small Study Found No Decrease in Mortality Among Inpatients in Three Countries; “Pfizer finally released results from its 2021-2022 trial showing that nirmatrelvir/ritonavir had no influence on symptoms among vaccinated patients with high risks or unvaccinated standard-risk patients. That study also found that hospitalizations were not statistically different across the nirmatrelvir/ritonavir and placebo groups.” — Dr. Jeremy Faust MD, MedPageToday link

13. Jun 9, 2024 — Paxlovid doesn’t help long Covid; The Biden Administration Gave Pfizer 10 billion dollars for a bad drug link

14. Sep 7, 2024 — A Systematic Review of Nirmatrelvir/Ritonavir and Molnupiravir for the Treatment of Coronavirus Disease 2019; “The overall pooled effects are nonsignificant, suggesting that recommendations and use of approved oral Covid-19 treatment therapies need to be reevaluated.” — Alyson Haslam & Dr. Vinay Prasad MD, MPH, Open Forum Infectious Diseases link

15. Sep 17, 2024 — Evidence Growing for Covid Antivirals to Cut Poor Outcomes, Long Covid, Experts Say; “A recently published systematic review and meta-analysis found no evidence that the antiviral drugs nirmatrelvir/ritonavir (Paxlovid) and molnupiravir (Lagevrio) help prevent Covid-19 hospitalization, death, or persistent symptoms” link

16. Oct 1, 2024 — Emerging SARS-CoV-2 Resistance After Paxlovid Treatment; Widespread Use of Pfizer Drug 2022-2024 Has Promoted Viral Resistance link

17. Oct 29, 2024 — Pfizer Rides Paxlovid Sales Growth to Better-Than-Expected Third Quarter; “A boost from Covid-19 treatment sales helped push Pfizer to a better-than-expected third quarter and higher forecast for the year. Demand for the drugmaker’s Paxlovid treatment spurred by the latest Covid-19 wave and a U.S. national stockpile delivery led to $2.7 billion in sales for the drug, Pfizer said. The drugmaker said it made a one-time delivery of a million Paxlovid treatment courses to the U.S. Strategic National Stockpile in the third quarter. Pfizer also saw sales of its Covid-19 vaccine Comirnaty grow 9% to $1.4 billion.” link

18. Apr 23, 2026 — “In two open-label trials, nirmatrelvir–ritonavir did not reduce the incidence of hospitalization or death among vaccinated higher-risk participants with SARS-CoV-2 infection.” — The New England Journal of Medicine link

19. May 7, 2026 — “The antiviral drug was rolled out worldwide based on little evidence it worked in real-world populations — yet it went on to generate about US$28 billion in sales for Pfizer.” link

This Facts at Your Fingertips series on Covid “public health” protocols provides quick access to hundreds of reports on the harms caused by standardized and mandated protocols.

1. Incentivized Standard of Care Failed & Caused Harm & Death — Care providers were incentivized to use a government-determined Covid standard of care and were excessively pressured to avoid any other measures. The Covid standard of care proved to cause harm and death.

2. Hospital Protocols Enriched Pharma, Made People Worse — The majority of Covid patients put on ventilators died. Molnupiravir increased infection. Paxlovid didn’t improve outcomes. Midazolam causes life-threatening breathing problems, permanent brain injury and death.

3. Remdesivir: A Failed & Deadly Drug — In 2019, Remdesivir was deemed too deadly to use. In 2020, government employee Anthony Fauci mandated and incentivized this failed and deadly drug as Covid standard of care. Hospitals complied.

4. “Lockdowns” Caused Severe Harm & Death — “Lockdowns” had no positive effect on public health, causing death and harm to elderly, youth and babies. Lockdowns caused economic devastation and a transfer of wealth, creating new billionaires.

5. Masking was Ineffective and Caused Harm — More than 80 references showing that masking was ineffective and caused harm, including a significant positive correlation between mask usage and excess deaths.

6. Excessive Pressure & Threats Were Used to Obtain Compliance — Independent and personalized healthcare decisions were actively discouraged, disparaged and prohibited. The institutions and leaders representing the “public health” protocols and mandates are verifiably corrupt.

7. Effective, Safe Treatments and Prevention Strategies Were Disregarded & Disparaged — Protocols did not boost natural immunity nor support wellness. Non-pharmaceutical therapies were disregarded, disparaged and prohibited. Safe healthcare options were denigrated and blocked.

8. Ivermectin & Covid — Establishment medicine disparaged and blocked access to safe, effective, life-saving treatment. More than 40 references, organized by: 1) Ivermectin Effectiveness with Covid, 2) Ivermectin’s Safety & Success Prior to 2020, and 3) FDA and Establishment Medicine Disparaged and Withheld Treatment.

9. Hydroxychloroquine & Covid — More than 15 references showing that establishment medicine disparaged and blocked access to hydroxychloroquine, a safe, effective, and life-saving treatment.

10. Excess Deaths — More than 100 references connecting excess deaths to Covid protocols via time or other evidence. For deaths connected more directly to Covid vaccines in particular, see: Covid Vaccine Harms: Deaths, Clots in Deceased.

Free Reference Guide — Cut through propaganda & distraction to efficiently get to suppressed evidence. Get an at-a-glance view for quick access to just what you need from thousands of the best sources.

Test it out: Ask AI about these subjects. While AI is better than compromised search engine slop, most answers require source verification and on these subjects, it censors and sometimes outright lies.

Stop building your classes, lectures, and handouts from scratch, and don’t risk your credibility on unverified, generic AI.

For over a decade, Wellness Resource Center and Yoga Teacher Central have served as the trusted back-office engine for teachers and wellness professionals. We vet and curate high-quality resources — never restricting your perspective, but expanding it with guided pathways and total transparency. You get instant access to evidence-based frameworks, wisdom teachings, and clinical summaries, plus the primary research to dig deep anytime you want. We handle the prep so you can lean into your true strengths: delivering individualized care and being fully present for those you serve.

• Evidence-Based Insights: Practical verifiable research delivered in context and designed for real-world application.

• Flexible Learning Pathways: A comprehensive knowledgebase that adapts to your changing needs.

• Turnkey Delivery Tools: Research summaries, lecture notes, workshop blueprints, and student handouts.

• Total Freedom: Customizable content with lifetime, royalty-free distribution rights.

• A Values-Aligned Community: A collaborative space for connection, inspiration, and shared growth.

Choose from two membership tracks:

Providers & Teachers ($12/mo annual, $22/mo installment) — Perfect for planning, teaching, coaching, and consultation preparation.

Associates ($400 one-time pay) — Perfect for trainers and educators. Includes downloadable, customizable content with lifetime distribution rights for workshops, courses, and presentations across 500+ subjects.